ADGN 531
Alternative Names: ADGN-531Latest Information Update: 22 Jun 2024
At a glance
- Originator Aanastra
- Class Antineoplastics; RNA
- Mechanism of Action Tumor suppressor protein p53 expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer